A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies (Q35483665)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies |
scientific article |
Statements
1 reference
A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies (English)
1 reference
Thorsten Zenz
1 reference
Karl-Heinz Heider
1 reference
Kerstin Kiefer
1 reference
Matthias Volden
1 reference
Elinborg Ostermann
1 reference
Anke Baum
1 reference
Herbert Lamche
1 reference
Zaruhi Küpcü
1 reference
Alexander Jacobi
1 reference
Steffen Müller
1 reference
Ulrich Hirt
1 reference
Günther R Adolf
1 reference
Eric Borges
1 reference
27 July 2011
1 reference
1 reference
118
1 reference
15
1 reference
4159-4168
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference